UK suspends Indian-origin neurosurgeon for misconduct

A patient does not enter an operating theatre only with pain. She also brings trust.

That is why the case of Dr Chirag Patel in the United Kingdom feels uncomfortable beyond one doctor’s suspension. A medical tribunal has suspended the Indian-origin neurosurgeon for eight months after finding serious misconduct involving a vulnerable patient, a sexual relationship, and controlled medicines prescribed outside proper safeguards.

For Indian readers, this is not just a “doctor abroad” story. It is a reminder of how much power sits inside a consultation room, especially when pain, dependence, and specialist care meet.

Tribunal finds serious misconduct

The Medical Practitioners Tribunal Service recorded that Patel worked as a consultant neurosurgeon at the University Hospital of Wales in Cardiff. The tribunal heard the case between March 30 and April 16, 2026.

The tribunal found his fitness to practise impaired because of misconduct. It ordered an eight-month suspension from medical practice. That means he cannot practise as a doctor in the UK during that period.

The case centred on a woman identified only as Patient A. The tribunal said Patel performed a discectomy on her in February 2019, another surgery in August 2019, and later inserted a spinal cord stimulator in December 2021.

A discectomy removes part of a damaged spinal disc. A spinal cord stimulator sends small electrical signals to reduce pain. Both sit in the serious end of pain treatment, not routine clinic care.

The tribunal found that Patient A was under Patel’s medical care. It also found she was vulnerable because of her physical health. Patel admitted having a sexual relationship with her and sending explicit images.

Why pain treatment raises stakes

This case is especially troubling because chronic pain can shrink a person’s choices. Anyone who has watched a family member struggle with back pain knows this. Pain changes sleep, work, mood, and dependence on doctors.

The tribunal records show that Patel had specialist skills in neuromodulation for pain and spasticity. In plain English, neuromodulation uses devices or signals to change how nerves carry pain messages.

That matters because patients in such situations often cannot easily switch doctors. A specialist may hold the map to their next surgery, next prescription, or next chance at relief.

In India, we see a similar pattern in big hospitals. Families often cling to one senior surgeon or specialist because they fear starting again. That trust can heal, but it can also expose patients when boundaries break.

Medical ethics draws a hard line here. Doctors should not form sexual or improper emotional relationships with current patients. Former-patient relationships can also become unsafe when vulnerability or dependence remains.

The tribunal said the clinical relationship continued during the material period. That is the heart of the matter. A doctor cannot treat a patient and privately cross boundaries with the same patient.

Controlled drugs outside safeguards

The tribunal also examined prescriptions between May 12, 2022 and January 10, 2023. It found Patel prescribed controlled medication to Patient A while they had a close personal relationship.

The medicines listed included morphine sulphate, also called MST, and diazepam. Morphine is an opioid painkiller. Opioids can help severe pain, but they can also cause dependence and dangerous side effects.

Diazepam belongs to a class called benzodiazepines. Doctors use it for anxiety, muscle spasm, and some other conditions. It can cause sleepiness, dependence, and withdrawal problems if used carelessly.

The issue was not simply that these medicines exist. Hospitals use such drugs every day when clinically needed. The issue was how they were prescribed.

The tribunal found Patel failed to record the prescriptions in Patient A’s hospital records. It also found he did not check with her general practitioner or inform the GP about the medicines.

That may sound like paperwork, but it is much more than that. Medical records are a patient’s safety net. They help doctors avoid dangerous combinations, repeated doses, and hidden dependency.

When a prescription sits outside the official trail, another doctor may not know what the patient is taking. That is how avoidable harm enters quietly, one missing note at a time.

The blackmail claim and response

Patel told the tribunal he acted under threats and pressure from Patient A. His counsel argued that blackmail formed part of the context behind the later prescribing.

The tribunal accepted that pressure formed part of the background. But it did not treat that as an answer to the professional breach. It still found the prescribing failures repeated over several months.

The General Medical Council argued through counsel that the conduct showed repeated abuse of professional position. The tribunal noted public protection, confidence in doctors, and professional standards while deciding the sanction.

Patel expressed remorse before the tribunal. The tribunal said he had shown insight and undertaken remediation. It also found that striking him off the medical register would be disproportionate in this particular case.

That last point may anger some readers. Many will ask why erasure did not follow. The tribunal’s answer was that the current risk was low, and suspension could mark the seriousness of the conduct.

This is where medical regulation often feels unsatisfying to the public. It weighs punishment, patient safety, remorse, service impact, and future risk. Ordinary people usually see a simpler question: did the doctor betray trust?

What patients should take away

The practical lesson is not to distrust every doctor. Most doctors do difficult work under pressure and still keep clean boundaries. The lesson is to understand what safe care should look like.

Patients should expect prescriptions to appear in their medical records. They should expect their family doctor or primary physician to know about controlled medicines. They should also expect clear reasons for strong painkillers.

Families can ask simple questions without sounding rude. What is this medicine for? How long should it continue? What side effects should we watch for? Has this been added to the record?

For chronic pain patients, these questions matter even more. Pain relief should not come with secrecy. It should come with a plan, a review date, and coordination between doctors.

Hospitals also need systems that do not depend only on a doctor’s personal judgment. Controlled medicines should leave a visible trail. Specialist care should include checks when one patient depends heavily on one clinician.

The case also says something larger about the Indian diaspora in medicine. Indian-origin doctors hold respected positions across the NHS and many other health systems. That pride should not make us defensive when misconduct appears.

A profession earns public trust by facing its failures, not hiding behind reputation. For patients, the message is equally clear. Trust your doctor, but trust proper records, second opinions, and boundaries too.

This article is for informational purposes only and does not substitute medical advice. Consult a qualified physician for any health concern.

This article is for informational purposes only and does not substitute medical advice. Consult a qualified physician for any health concern.